MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Morad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Morad, M.

Vol. 55, Issue 6, 970-981, June 1999

Activation and Ca2+ Permeation of Stably Transfected alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor

J. Zhang, Y. Xiao, G. Abdrakhmanova, W. Wang, L. Cleemann, K.J. Kellar, and M. Morad

Department of Pharmacology, Georgetown University School of Medicine, Washington, D.C.

The alpha 3/beta 4 rat neuronal nicotinic acetylcholine receptor, stably transfected in human embryonic kidney cells, was examined using the whole-cell-clamp technique and 2-dimensional confocal imaging. Application of agonists (nicotine, cytisine, epibatidine) activated a large (100-200 pA/pF) inwardly rectifying monovalent current, with little current at voltages between 0 and +40 mV. Rapid application of nicotine and cytisine indicated EC50 values of congruent 22 and congruent 64 µM, respectively, and suggested second order binding kinetics (Hill coefficient ~2). The time constant of desensitization (decay) of nicotine-activated current was concentration-dependent (typically ~10 s at 30 µM versus ~1.0 s at 100-1000 µM), but not voltage-dependent and was significantly smaller than the ~200 s reported for the alpha 3/beta 4 receptor expressed in Xenopus oocytes. Nicotine-activated current was rapidly and reversibly blocked by coapplication of mecamylamine and d-tubocurarine. At -80 mV holding potentials, the current was also suppressed by ~25% either upon complete removal or elevation of Ca2+ to 10 mM. Total replacement of Na+ by Ca2+ also completely blocked the current. On the other hand, evidence for permeation of Ca2+ was indicated by increased inward current at -40 mV upon elevation of Ca2+ from 2 to 10 mM, as well as a rise in the cytosolic Ca2+ proportional to the current carried by the receptor. These findings are consistent with the idea that Ca2+, in addition to its channel-permeating properties, may also regulate the receptor from an extracellular site. Our results suggest that the alpha 3/beta 4 neuronal nicotinic acetylcholine receptor, when stably expressed in human embryonic kidney 293 cells, has desensitization kinetics and Ca2+ regulatory mechanisms somewhat different from those described for the receptor expressed in Xenopus oocytes.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. R. Abdrakhmanova, M. I. Damaj, F. I. Carroll, and B. R. Martin
2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine Is a Novel Potent Competitive Antagonist of Human Neuronal {alpha}4beta2 nAChRs
Mol. Pharmacol., June 1, 2006; 69(6): 1945 - 1952.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, L. Cleemann, J. Lindstrom, and M. Morad
Differential Modulation of {beta}2 and {beta}4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification
Mol. Pharmacol., August 1, 2004; 66(2): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao and K. J. Kellar
The Comparative Pharmacology and Up-Regulation of Rat Neuronal Nicotinic Receptor Subtype Binding Sites Stably Expressed in Transfected Mammalian Cells
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Moccia, C. Frost, R. Berra-Romani, F. Tanzi, and D. J. Adams
Expression and function of neuronal nicotinic ACh receptors in rat microvascular endothelial cells
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H486 - H491.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. Fitch, Y. Xiao, K. J. Kellar, and J. W. Daly
Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function
PNAS, April 15, 2003; 100(8): 4909 - 4914.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Sala, J. Mulet, S. Choi, S.-Y. Jung, S.-Y. Nah, H. Rhim, L. M. Valor, M. Criado, and S. Sala
Effects of Ginsenoside Rg2 on Human Neuronal Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1052 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, J. Dorfman, Y. Xiao, and M. Morad
Protons Enhance the Gating Kinetics of the alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor by Increasing Its Apparent Affinity to Agonists
Mol. Pharmacol., February 1, 2002; 61(2): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. L. Meyer, Y. Xiao, and K. J. Kellar
Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Giniatullin, E. M. Sokolova, S. Di Angelantonio, A. Skorinkin, M. V. Talantova, and A. Nistri
Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
Mol. Pharmacol., October 1, 2000; 58(4): 778 - 787.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics